Moderna Inc at BMO Capital Markets Prescription for Success Healthcare Conference Transcript
Good afternoon, everyone. My name is George Farmer. I'm a biotechnology analyst here at BMO. It's my pleasure to have Pam Cohen here with us here from Moderna. She's the head of Oncology Clinical Development at the company. And she's going to talk to us about Moderna's platform and its application in oncology indication specifically, and how Moderna is using messenger RNA-based vaccines for treating cancer.
Questions & Answers
So Pam, why don't we start off, perhaps you could just walk us through the approach that Moderna is using involving messenger RNA-based vaccine?
Sure. And thank you for having me, George. So we know that mutation-derived epitopes are important to activate T cells in patients with cancer and they drive, to some extent, the antitumor response that is seen with checkpoint inhibitors, and that's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |